Skip to content

Visual and Economic Profits of ReSTOR® Multifocal Intraocular Lenses (IOL) on Public Health Patients in Spain

Visual Function, Non-dependence on Glasses and Global Economic Cost in Patients Undergoing Lens Surgery With ReSTOR® Multifocal Aspheric Iol Implants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01088282
Enrollment
120
Registered
2010-03-17
Start date
2010-03-31
Completion date
2011-03-31
Last updated
2010-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Keywords

Diffractive multifocal IOL

Brief summary

Surgical correction of presbyopia is possible via the implantation of multifocal intraocular lenses after removal of the crystalline lens. The cost of these implants is approximately 6 times higher than the conventional monofocal implants routinely used in all crystalline surgery for correction of the resulting ametropia. Spectacles for correcting presbyopia, which are necessary after the insertion of monofocal implants, may also have a significant cost. The proposed trial will involve two randomized groups of patients in need of crystalline/cataract surgery, with monofocal or multifocal lens implants (the same type of lens in both eyes) leaving them emmetropic for distant vision. The objective is to corroborate with blind-evaluation the effectiveness of multifocal lens implants in obviating the need for glasses to correct presbyopia, to evaluate the benefits of this type of implant, both in global economic terms (adding the cost of the implants to that of corrective glasses where necessary) and in terms of the improved quality of life of the patients, and to confirm the absence of adverse effects. Findings will be subjected to a statistical quantification.

Interventions

PROCEDURECataract surgery

Implantation of multifocal or monofocal IOL

Sponsors

University of Barcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of both sexes aged 50 and over, with fully-established presbyopia, requiring phacoemulsification + IOL as the surgical technique for the removal of their cataracts. * Their capsular bags should be stable, with keratometric astigmatism equal to or lower than 1 diopter. * Biometric calculations should indicate an IOL for emmetropy within the common dioptric range for both lenses, i.e. between +6 y +34.

Exclusion criteria

* Previous corneal refractive surgery * Maculopathy, amblyopia or other eye conditions that limit visual power * Occupations requiring special driving licenses * Keratometric astigmatism higher than 1 diopter * Any intraoperative posterior capsular rupture or extracapsular reconversion.

Design outcomes

Primary

MeasureTime frame
Visual function quality (VF-14)At 1 and 3 months post-intervention

Secondary

MeasureTime frame
Visual acuity with and without correctionat 1 and 3 months post-intervention
Determine Expense in glassesat 3 months post-intervention

Countries

Spain

Contacts

Primary ContactJosep Torras, MD
jtorras@clinic.ub.es+34 932275667

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026